Who We Are

We are a diverse and international team of finance and life sciences experts with deep industry experience. We offer you evidence-based and transparent analytics to empower your business.

We are a team of physicians and scientists with extensive experience in Pharma, Biotech and Medtech, and of experts in finance and economic modelling. We provide deep analytical insights at the interface of finance and life sciences. In our history of more than 20 years we have established ourselves as trusted partner for C-level Pharma, Biotech and MedTech executives and their investors.

We advise start-up, maturing, and fully integrated companies in making value-driven decisions. Our evidence-based valuation approach is used for the prioritization of assets, the optimization of business strategy, value-centric company reorganization and the negotiation of acquisitions, licensing deals, financings, investments and IPOs. In addition, we are frequently asked to take the lead as a moderator in negotiations to ensure alignment of interests of all stake- and shareholders.



Boston/New York

LaVoieHealthScience (LHS), Boston / New York, and Bioscience Valuation BSV GmbH (BSV) announced a strategic alliance between the two firms in June 2020. The alliance combines LHS’ expertise in strategic communication for companies at the forefront of healthcare and science innovation with BSV’s skill in providing financial valuations for life science companies. (see press release 2020, June 24)

Fox Corporate Finance GmbH,

The Life Sciences Team at Fox Corporate Finance GmbH („FCF“), Munich, is collaborating with BioScience Valuation BSV GmbH („BSV“) as part of a new strategic alliance that aims to combine the expertise and networks of both companies: FCF promises strong competence in corporate finance and capital markets, while BSV boasts profound valuation expertise for the special demands in the Health Care and Life Sciences sectors. (see press release 2020, May 20)